• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health

    9/23/25 4:10:00 PM ET
    $EVH
    $PRVA
    Other Consumer Services
    Consumer Discretionary
    Medical/Nursing Services
    Health Care
    Get the next $EVH alert in real time by email

    ARLINGTON, Va., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that it signed a definitive agreement to acquire an Accountable Care Organization (ACO) business from Evolent Health, Inc. (NYSE:EVH). The ACO business cares for over 120,000 attributed lives through the Medicare Shared Savings Program (MSSP), as well as various commercial and Medicare Advantage programs. With this transaction, Privia Health will now serve approximately 1.5 million attributed lives in value-based care (VBC) arrangements across commercial, Medicare, Medicare Advantage and Medicaid.

    Privia Health will pay $100 million in cash at closing and up to an additional $13 million subject to final MSSP performance for 2025. The transaction is expected to close in the fourth quarter of 2025, and is expected to positively contribute to Adjusted EBITDA in 2026. The Company will finance the transaction with cash on its balance sheet.

    This strategic transaction increases VBC attributed lives in existing Privia states, adds lives in new states, and also offers a compelling synergy opportunity for the ACO-participating providers to join Privia's Medical Groups for a full suite of services and technology platform.

    "The addition of Evolent Health's ACO business to our existing national network of ACOs reaffirms Privia Health's ability to replicate our highly differentiated and flexible operating model with new provider partners across the U.S. ," said Sam Starbuck, SVP and President, Privia Care Partners, Privia Health. "We look forward to collaborating with the physicians and their practices, and leveraging our population health and value-based care expertise to enhance the patient experience, improve outcomes and lower costs."

    About Privia Health

    Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 15 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,300+ physician practices, improve the patient experience for 5.3+ million patients, and reward 5,100+ physicians and advanced practitioners for delivering high-value care.

    Privia's mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com and connect with us on LinkedIn.

    Safe Harbor Statement

    This release may contain forward-looking statements within the meaning of the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements relate to our current expectations, projections and assumptions about our business, the economy and future events or conditions. They do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as "aims," "anticipates," "assumes," "believes," "estimates," "expects," "forecasts," "future," "intends," "likely," "may," "outlook," "plans," "potential," "projects," "seeks," "strategy," "targets," "trends," "will," "would," "could," "should," and variations of such terms and similar expressions and references to guidance, although some forward-looking statements may be expressed differently. In particular, these include statements relating to, among other things: our future actions, business plans, objectives and prospects; and our future operating or financial performance and projections, including our full-year guidance for 2025. Factors or events that could cause actual results to differ may emerge from time to time and are difficult to predict. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results may differ materially from past results and those anticipated, estimated or projected. We caution you not to place undue reliance upon any of these forward-looking statements.

    Factors related to these risks and uncertainties include, but are not limited to: the heavily regulated industry in which we operate, and any failure by us or our medical groups to comply with the extensive applicable healthcare laws and government regulations; the complexity of the legal framework governing our relationships with Medical Groups, some of which we do not own, and Privia providers, and the impact of legal challenges or shifting interpretations of applicable laws; the execution of our growth strategy, which may not prove viable and we may not realize expected results; difficulties timely implementing our proprietary end-to-end, cloud-based technology solution for Privia physicians and new medical groups; the high level of competition in our industry; challenges in successfully establishing a presence in new geographic markets; the impact of failures by or service disruptions at key third-party vendors, such as our primary electronic medical record vendor, athenahealth, Inc.; potential decreases in reimbursement rates by governmental and third-party payers, changes to payment terms or challenges negotiating and retaining favorable contracts with private third-party payers, and changes impacting our patient population; the financial and operational impact of our compliance with various complex and changing federal and state privacy and security laws and regulations related to our use, disclosure, and other processing of personal information and protected health information, including the Health Insurance Portability and Accountability Act of 1996; the impact of actual and potential security threats, cybersecurity incidents or privacy or other forms of data breaches involving us, our vendors or other third parties; the continued availability of qualified workforce, including staff at our medical groups, and the continued upward pressure on compensation for such workforce; and other risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2024 and the Company's subsequent Quarterly Reports on Form 10-Q. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.

    Contact:

    Robert Borchert

    SVP, Investor & Corporate Communications

    IR@priviahealth.com

    817.783.4841



    Primary Logo

    Get the next $EVH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EVH
    $PRVA

    CompanyDatePrice TargetRatingAnalyst
    Evolent Health Inc
    $EVH
    2/25/2026Overweight → Sector Weight
    KeyBanc Capital Markets
    Privia Health Group Inc.
    $PRVA
    1/9/2026$31.00Outperform
    RBC Capital Mkts
    Evolent Health Inc
    $EVH
    11/13/2025$7.00Equal-Weight → Overweight
    Stephens
    Privia Health Group Inc.
    $PRVA
    11/13/2025$30.00Outperform
    BMO Capital Markets
    Evolent Health Inc
    $EVH
    11/13/2025$7.00Outperform
    BMO Capital Markets
    Privia Health Group Inc.
    $PRVA
    1/10/2025$25.00Buy
    Needham
    Evolent Health Inc
    $EVH
    1/10/2025$15.00Buy
    Needham
    Privia Health Group Inc.
    $PRVA
    12/16/2024Outperform
    Macquarie
    More analyst ratings

    $EVH
    $PRVA
    SEC Filings

    View All

    Evolent Health Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Evolent Health, Inc. (0001628908) (Filer)

    6/4/26 4:05:16 PM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary

    Privia Health Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Privia Health Group, Inc. (0001759655) (Filer)

    5/22/26 8:00:45 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    SEC Form 144 filed by Privia Health Group Inc.

    144 - Privia Health Group, Inc. (0001759655) (Subject)

    5/11/26 3:29:39 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $EVH
    $PRVA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evolent Health downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Evolent Health from Overweight to Sector Weight

    2/25/26 7:39:36 AM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary

    RBC Capital Mkts initiated coverage on Privia Health with a new price target

    RBC Capital Mkts initiated coverage of Privia Health with a rating of Outperform and set a new price target of $31.00

    1/9/26 8:12:05 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Evolent Health upgraded by Stephens with a new price target

    Stephens upgraded Evolent Health from Equal-Weight to Overweight and set a new price target of $7.00

    11/13/25 9:38:39 AM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary

    $EVH
    $PRVA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Springstubb Brendan B bought $38,199 worth of shares (10,000 units at $3.82), increasing direct ownership by 20% to 58,821 units (SEC Form 4)

    4 - Evolent Health, Inc. (0001628908) (Issuer)

    11/19/25 4:23:02 PM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary

    Director Holder Diane bought $25,518 worth of shares (2,735 units at $9.33), increasing direct ownership by 4% to 70,584 units (SEC Form 4)

    4 - Evolent Health, Inc. (0001628908) (Issuer)

    3/10/25 8:20:54 AM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary

    PRESIDENT Mccarthy Daniel Joseph bought $99,470 worth of shares (11,040 units at $9.01), increasing direct ownership by 3% to 389,004 units (SEC Form 4)

    4 - Evolent Health, Inc. (0001628908) (Issuer)

    3/10/25 8:18:12 AM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary

    $EVH
    $PRVA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $EVH
    $PRVA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Privia Health Enters New Jersey

    ARLINGTON, Va., May 27, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA), a national physician enablement company, announced it has signed a definitive agreement to enter the state of New Jersey in partnership with Neurology Group of Bergen County (NGBC), a practice with 25 adult and pediatric clinicians. NGBC will serve as the anchor practice for Privia Medical Group—New Jersey and is expected to be implemented on the Privia Platform by year-end 2026. Privia Health will provide an alternative for community clinicians in New Jersey to care for patients across all reimbursement models, leveraging a breadth of interoperable solutions and population health expertise to enable

    5/27/26 9:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer

    Accomplished product leader to drive innovation, platform strategy, and AI-powered solutions for health plan clientsOVERLAND PARK, Kan., May 12, 2026 /PRNewswire/ -- Quest Analytics® today announced the appointment of Chris Lance as Chief Product Officer (CPO). In this role, Lance will lead vision, strategy, and execution across the company's full product portfolio, driving innovation that helps health plans build, manage, model, and optimize high-performing provider networks. Lance brings more than 20 years of experience leading product and technology organizations, with a prov

    5/12/26 7:00:00 AM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary

    Evolent Announces First Quarter 2026 Results

    WASHINGTON, May 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended March 31, 2026.Seth Blackley, Co-Founder and Chief Executive Officer of Evolent stated, "I am happy with the strong start to the year. We are on track with our plan and have had successful, on-time oncology launches at both Highmark and Aetna. As we look into 2027 and beyond, we remain focused on both extending our market leadership in oncology and addressing the big opp

    5/7/26 7:00:00 AM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary

    Director Soistman Francis S Jr was granted 8,463 shares (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    5/22/26 8:26:40 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Director Berberian Lance was granted 8,463 shares, increasing direct ownership by 110% to 16,131 units (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    5/22/26 8:26:23 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Director Cocozza Nancy G was granted 8,463 shares, increasing direct ownership by 25% to 42,814 units (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    5/22/26 8:26:07 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $EVH
    $PRVA
    Financials

    Live finance-specific insights

    View All

    Evolent Announces First Quarter 2026 Results

    WASHINGTON, May 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended March 31, 2026.Seth Blackley, Co-Founder and Chief Executive Officer of Evolent stated, "I am happy with the strong start to the year. We are on track with our plan and have had successful, on-time oncology launches at both Highmark and Aetna. As we look into 2027 and beyond, we remain focused on both extending our market leadership in oncology and addressing the big opp

    5/7/26 7:00:00 AM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary

    Privia Health Reports First Quarter 2026 Financial Results

    Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the first quarter ended March 31, 2026.   Three Months Ended March 31,  (unaudited; $ in millions, except per share amounts) 2026 2025 Change (%)*       Total revenue $603.8 $480.1 25.8%Gross profit $125.6 $103.6 21.2%Operating income $7.4 $5.2 42.2%Net income a $3.1 $4.2 (27.4)%Non-GAAP adjusted net income b $24.3 $19.9 22.3%Net income per share $0.02 $0.03 (33.3)%Non-GAAP adjusted net income per share b $0.19 $0.16 18.8%        * Any slight

    5/7/26 6:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Privia Health to Report First Quarter 2026 Results on Thursday, May 7

    ARLINGTON, Va., April 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2026 before market open on Thursday, May 7, 2026. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, May 7, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations to li

    4/8/26 9:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $EVH
    $PRVA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

    SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

    11/14/24 5:20:21 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

    SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

    11/12/24 10:34:17 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Evolent Health Inc

    SC 13G/A - Evolent Health, Inc. (0001628908) (Subject)

    11/12/24 9:55:15 AM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary

    $EVH
    $PRVA
    Leadership Updates

    Live Leadership Updates

    View All

    Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer

    Accomplished product leader to drive innovation, platform strategy, and AI-powered solutions for health plan clientsOVERLAND PARK, Kan., May 12, 2026 /PRNewswire/ -- Quest Analytics® today announced the appointment of Chris Lance as Chief Product Officer (CPO). In this role, Lance will lead vision, strategy, and execution across the company's full product portfolio, driving innovation that helps health plans build, manage, model, and optimize high-performing provider networks. Lance brings more than 20 years of experience leading product and technology organizations, with a prov

    5/12/26 7:00:00 AM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary

    Evolent announces appointment of Archie Mayani as chief product officer

    Industry veteran brings track record of innovation from GHX, Change Healthcare, UnitedHealth Group and Amazon.WASHINGTON, March 19, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced the appointment of health care technology leader and AI innovator Archie Mayani as chief product officer (CPO).Mayani brings more than two decades of leadership experience across health care, enterprise platforms, and AI, with a history of building products that improve clinical and business outcomes at scale.Before joining Evolent, she served as CPO at GHX, where she helped pioneer AI-powered capabilitie

    3/19/26 8:45:00 AM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary

    Foodsmart Appoints Cityblock Health Co-Founder and CEO Dr. Toyin Ajayi to Board of Directors

    National leader in value-based care joins as Foodsmart scales foodcare for Medicaid populationsSAN FRANCISCO, March 18, 2026 /PRNewswire/ -- Foodsmart, the leading telenutrition and foodcare provider nationwide, today announced the appointment of Dr. Toyin Ajayi to its Board of Directors. A board-certified Family Medicine physician and the co-founder and CEO of Cityblock Health, Dr. Ajayi brings deep experience serving Medicaid and dually eligible populations through value-based care models designed to improve outcomes and lower total cost of care. For millions of Americans, foo

    3/18/26 9:11:00 AM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary